Thank you! Your form has been received!
Oops! Something went wrong while submitting the form.

The long-term storage of sensitive biological samples requires more than just low-temperature technology. Validated processes, redundant systems, and continuous monitoring are crucial. Consarctic develops comprehensive cryopreservation solutions for stem cells and cell therapies that meet the highest GMP requirements and offer maximum process reliability.
Cell therapy products are highly sensitive, valuable, and subject to stringent regulatory requirements. Consarctic combines technological excellence, GMP expertise, and decades of experience in developing safe cryopreservation solutions.
Successful cryopreservation begins long before the actual storage. Every process step must be precisely controlled and coordinated to avoid cell damage and comply with regulatory requirements.


The controlled freezing process prevents the formation of harmful ice crystals and ensures the structural integrity of the cells. After freezing, the cells are safely transferred to validated cryostorage systems, where stem cells and cell therapies are stored permanently. Consarctic ensures that all transfers are seamless, documented, and GMP-compliant.
Consarctic offers modular, scalable cryopreservation solutions that can be flexibly adapted to growing production capacities and new therapeutic approaches. Whether for research laboratories, biotech companies, or industrial cell therapy production – our systems are designed for the future.
Cryostorage systems combine automated nitrogen supply, intelligent control, and validated hardware into a seamless GMP infrastructure. The result: reproducible processes, minimized operating costs, and maximum safety for sensitive cell therapies.
Cell therapies are extremely sensitive to temperature fluctuations and process errors. A specialized infrastructure ensures that cell quality and regulatory compliance are guaranteed at all times.
Stable cryogenic temperatures, controlled freezing processes and continuous monitoring allow cells to be stored for decades without loss of quality.
An integrated solution significantly reduces interfaces, minimizes sources of error, and simplifies validation, operation, and maintenance.
Storage must be validated, documented, monitored, and traceable. This includes qualified systems, alarm scenarios, emergency plans, and regular re-validations.
Redundant temperature and level sensors, real-time monitoring, automated alarms, and auditable data storage are recommended.
Are you planning a new cryo-infrastructure or would you like to expand existing systems in compliance with GMP? The experts at Consarctic will advise you individually – from the concept phase to the long-term operation of your cryopreservation solution for stem cells and cell therapies.